Stoekenbroek, Robert M <br/><br/>
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.  [electronic resource] 

 -  Heart (British Cardiac Society)  Mar 2015 
 - 356-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-201X 
<br/><br/><label>Standard No.: </label>10.1136/heartjnl-2014-306906  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Atorvastatin<br/>Cholesterol, LDL--blood<br/>Dose-Response Relationship, Drug<br/>Female<br/>Heptanoic Acids--administration & dosage<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Incidence<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--epidemiology<br/>Myocardial Revascularization--statistics & numerical data<br/>Netherlands--epidemiology<br/>Peripheral Arterial Disease--epidemiology<br/>Prospective Studies<br/>Pyrroles--administration & dosage<br/>Scandinavian and Nordic Countries--epidemiology<br/>Simvastatin--administration & dosage